- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
180 |
5 Multi Cystic Dysplastic Kidney (MCDK) |
|
|
5.7Associated Anomalies
•Multicystic dyplastic kidney is associated with contralateral renal disease in a significant number of patients.
•Previous reports have shown that MCDK is associated with a 20–45 % incidence of contralateral renal anomalies.
•The most common contralateral abnormality was vesicoureteral reflux and ureteropelvic junction obstruction.
•Bilateral MCDK was reported in 19 % and contralateral renal agenesis in 11 %.
•Contralateral hydronephrosis was seen in 7 %.
•30–35 % of fetuses with MCDK have associated non-renal abnormalities.
•The most common abnormalities were those of the heart, followed by the spine, extremities, face and umbilical cord.
•Fetuses with bilateral MCDK are more likely to have associated non-renal abnormalities (66.7 %) in comparison with fetuses with unilateral MCDK (25.6 %).
•Abnormal chromosomes:
–Abnormal chromosomes (10 %).
–Female fetuses (20 %) are more likely to have an abnormal chromosome study than male fetuses (5.6 %).
–Fetuses with bilateral MCDK disease (16.7 %) are more likely to have an abnormal karyotype than fetuses with unilateral MCDK (7.7 %).
–No karyotype abnormalities were found in fetuses with unilateral MCDK if an associated non-renal abnormality was not found.
•The ratio of male to female fetuses was 2.4:1.
•Female fetuses were twice as likely to have bilateral MCDK as males.
•Vesicoureteic reflux in the contralateral kidney (23 %).
•As most patients with multicystic dysplastic kidneys have pelvo-ureteral atresia on the affected side, it is unlikely that infected urine will reflux into the kidney.
•Multicystic dysplastic kidney has been reported in various syndromes, including the following:
–49,XXXXX syndrome (hypertelorism, epicanthic folds, microcephaly, short neck, clinodactyly of the fifth finger, small hands and feet, and mental retardation).
–Alagille syndrome (liver disease, cardiac defects, characteristic facies, renal anomalies, vascular anomalies and anomalies of the eye, pancreas, and skeletal system. The condition is associated with mutations in the JAG1 gene that encodes for a ligand of Notch.
–Beckwith-Wiedemann syndrome (macrosomia, microcephaly, macroglossia, visceromegaly, omphalocele, and hypoglycemia).
–Branchio-oto-renal (BOR) syndrome (hearing loss, ear malformations, branchial cleft fistulas or cysts, and renal dysplasia or renal agenesis. The BOR syndrome is an autosomal dominant condition caused by mutations in the EYA1 and SIX1 genes.
–Hypoparathyroidism-deafness-renal syndrome (sensorineural deafness, hypoparathyroidism, and urinary tract anomalies, including renal dysplasia). This autosomal dominant syndrome is caused by mutations in the GATA3 transcription factor.
–Joubert syndrome (hypoplasia of the cerebellar vermis, hypotonia, and impaired psychomotor development together with abnormal respiratory pattern, abnormal eye movements with poor vision, or both). This syndrome is an autosomal recessive condition.
–Maturity-onset diabetes of the young type V (MODY5): MODY5 is a monogenic form of diabetes with an autosomal dominant mode of inheritance caused by mutations in the hepatocyte nuclear factor 1-beta mutations. Patients present with diabetes, usually when younger than 25 years, with a wide spectrum of renal anomalies, including cystic dysplasia.
–Renal coloboma syndrome (RCS): The RCS is an autosomal dominant condition caused by mutations in the transcription factor PAX2 and characterized by optic
5.7 Associated Anomalies |
181 |
|
|
nerve coloboma and renal malformations, including dysplasia.
–Trisomy 18: Patients with trisomy 18 have a prominent occiput, micrognathia, low-set ears, and flexion deformities of the fingers, congenital heart disease, and mental retardation.
–VACTERL association: The VACTERL association refers to the combination of vertebral defects (V), anal atresia (A), cardiovascular anomalies (C), tracheoesophageal fistula (TE), renal anomalies (R), and limb defects (L). In 20 % of these patients, cystic renal disease may be found.
–Waardenburg syndrome type 1: Patients present with developmental anomalies of the eyelids, eyebrows, and nose root; pigmentary defects of the iris and hair; and congenital deafness.
–Williams’ syndrome: This syndrome is characterized by elfin facies, mental retardation, supravalvular aortic stenosis, and neonatal hypercalcemia.
•Nonrenal malformations reported in patients with multicystic dysplastic kidney include the following:
–Gastrointestinal malformations:
•Duodenal atresia
•Esophageal atresia
•Hirschsprung’s disease
•Anorectal malformations
•Inguinal hernia
•Omphalocele
•Tracheoesophageal fistula
–Neurologic malformations
•Anencephaly
•Caudal agenesis
•Caudal regression syndrome
•Congenital deafness
•Hydrocephalus
•Mental retardation
•Microcephaly
•Microphthalmia
•Myelomeningocele
•Spina bifida
–Cardiovascular malformations
•Aortic stenosis
•Coarctation of the aorta
•Patent ductus arteriosus
•Pulmonary stenosis
•Truncus arteriosus
•Ventricular septal defect
–Musculoskeletal
•Clinodactyly of the fifth finger
•Congenital dislocation of the hip
•Flexion deformities of the fingers
•Syndactyly
•Talipes equinovarus
–Miscellaneous
•Bipartite uterus
•Cleft palate
•Epicanthic folds
•Hymenal atresia
•Hypertelorism
•Low-set ears
•Macroglossia
•Macrosomia
•Micrognathia
•Pigmentary defects of iris and hair
•Preauricular pit
•Short neck
•Urinary malformations associated with multicystic dysplastic kidney include the following:
–Bladder wall diverticulum
–Contralateral renal agenesis
–Dysplasia
–Hypoplasia
–Crossed fused renal ectopia
–Cystic dysplasia of the testis
–Ectopic kidney
–Fibromuscular dysplasia
–Horseshoe kidney
–Patent urachus
–Seminal vesicle abnormalities
–Ureterocele
–Contralateral ureteropelvic junction obstruction has been reported in 7–12 % of patients.
–Posterior urethral valves
–Contralateral vesicoureteral reflux is reported in 4–19 % of patients.
•In children older than 2 years, 72 % of patients with multicystic dysplastic kidney showed compensatory growth of the contralateral kidney.
182 |
5 Multi Cystic Dysplastic Kidney (MCDK) |
|
|
5.8Clinical Features
•Most cases of multicystic dysplasia of the kidney (MCDK) are detected during fetal ultraso-
nography and are reported as early as 15 weeks’ gestation.
•An abdominal mass in the flank of an otherwise healthy newborn was the most common clinical presentation of unilateral multicystic dysplastic kidney.
•The abnormal kidney is palpable in only 13–22 % of patients.
•The mass is usually mobile, ballotable, and irregular in shape, nontender, and might transilluminate.
•Multicystic dysplastic kidney is usually asymptomatic and can remain undetected into adulthood.
•Abdominal or flank pain and respiratory distress are uncommon symptoms because of the pressure effect of the abnormal kidney.
•Multicystic dysplastic kidney might be discovered during an investigation for urinary tract infection (UTI), voiding dysfunction, or hypertension. Multicystic dysplastic kidney may also be discovered when diagnostic imaging studies are performed to investigate a nonurinary problem.
•Bilateral multicystic dysplastic kidney usually results in stillbirth or death within the first few days of life; however, an infant with bilateral multicystic dysplastic kidney who survived for 17 days was reported.
•Bilateral multicystic dysplastic kidney is usually associated with oligohydramnios, amnion nodosum, pulmonary hypoplasia, and Potter facies.
•Infants with bilateral multicystic dysplastic kidney who survive have renal failure from birth and require dialysis from the first day of life.
5.9Investigations
•CBC
•Serum electrolytes, BUN and creatinine
•Urine analysis and culture
•Abdominal radiograph may show a soft tissue density with displacement of the bowels in
those with enlarged MCDK. Rarely, ring like calcifications of the cyst walls may be seen on plain radiographs.
•Abdominal ultrasound is the preferred initial examination.
–Ultrasonography is an excellent diagnostic test for MCDK, with a high degree of confidence.
–Currently, the majority of MCDK cases are diagnosed by antenatal ultrasound examination.
–Abdominal ultrasound is accurate, and it does not require sedation, radiation, and can be repeated easily.
–The cysts of MCDK may become enlarged, may shrink, or may involute during fetal life.
–Bilateral MCDK may occur with oligohydramnios as a result of poor urine production.
–In patients with a prenatal diagnosis of MCDK, a postnatal ultrasound should be done prior to discharge to differentiate MCDK from hydronephrosis.
–Abdominal ultrasounds characteristically show:
•Hypoechoic cysts of variable sizes and shapes
•Interfaces between cysts
•A nonmedial location of large cysts
•The absence of an identifiable renal sinus
•Lack of communication between cysts
•Minimal surrounding parenchyma
–An obstructive uropathy with little renal parenchyma can mimic MCDK, but radionuclide studies can provide confirmation of the diagnosis.
–The presence of a kidney shape and/or a large cystic structure in the medial portion of the kidney on ultrasound evaluation are more suggestive of hydronephrosis than MCDK. In MCDK, the cysts do not communicate, while in hydronephrosis there is communication with the central renal pelvis.
–The autosomal recessive polycystic kidney disease (PCKD) is not usually mistaken for MCDK, as the cysts in PCKD are too small
5.10 Treatment |
183 |
|
|
to be visualized on sonograms, and the parenchyma is generally homogeneously hyperechoic.
•Radionuclide scan:
–Radionuclide scan is useful in differentiating an obstructed functioning kidney from MCDK.
–Radionuclide scan may be necessary if ultrasonography does not reveal the classic features of multicystic dysplasia of the kidney.
–Radionuclide scan is useful in estimating the function of the involved kidney.
–Technetium-99m (99mTc) mercaptoacetyltriglycine (MAG-3) and 99mTc dimercaptosuccinic acid (DMSA) studies can demonstrate lack of function in the affected kidney, but MAG-3 and DTPA studies can also provide information regarding drainage in an obstructed hydronephrotic kidney.
–The hydronephrotic form of MCDK can mimic ureteropelvic junction obstruction, and radionuclide scanning is necessary to confirm the diagnosis.
–On radionuclide scan, the area of the MCDK appear as a photopenic region that represents displaced tissue with background activity only.
–DMSA renal scanning demonstrates absence of function in the kidney with multicystic dysplastic kidney.
•Voiding cystourethrography (VCUG):
–This is useful in patients with MCDK to evaluate for vesicoureteral reflux (VUR).
–VUR could lead to reflux nephropathy in the contralateral solitary kidney.
–Current recommendations for patients with unilateral multicystic dysplastic kidney include evaluation of the contralateral kidney for VUR by VCUG.
–VUR has been reported in 4–19 % of contralateral kidneys but it is usually low grade and resolves in early life.
–VCUG may be deferred, unless abnormal ultrasonography findings in the contralateral kidney or ureter and/or a history of UTI are noted.
•Intravenous pyelography (IVP):
–This is not usually necessary; however, if multicystic dysplastic kidney involves only the upper or lower segment of a duplicated system, an IVP might reveal a small but functional ipsilateral kidney with an incomplete and possibly dilated calyceal system.
•Abdominal CT-scan is also rarely done to diagnose MCDK (Figs. 5.12, 5.13, 5.14, 5.15, and 5.16).
–Abdominal CT-scan show the typical multicystic appearance of MCDK with little or no parenchyma. Cyst wall calcification may be seen also.
–If a contrast-enhanced CT scan is performed, there is no excretion seen.
•Retrograde pyelography is rarely done to demonstrate an atretic or absent ureter. This is usually done through a cystoscope.
–Retrograde pyelography demonstrates a ureter that terminates blindly below the ureteropelvic junction.
•Abdominal MRI:
–This show the typical multicystic appearance of MCDK with little or no parenchyma.
5.10Treatment
•In the past, nephrectomy was often performed to establish the diagnosis.
•Currently, the role of nephrectomy in multicystic dysplasia of the kidney (MCDK) is controversial.
•The indications for nephrectomy in multicystic dysplasia of the kidney are:
–Large multicystic dysplastic kidney causing abdominal or flank pain
–Urinary tract infection (UTI)
–Hypertension
–Renal malignancy
•Multicystic dysplasia of the kidney can attain a large size and cause significant abdominal or flank discomfort and pain and these should be removed.
•Urinary tract infection involving the multicystic dysplastic kidney calls for its removal.
184 |
5 Multi Cystic Dysplastic Kidney (MCDK) |
|
|
Figs. 5.12, 5.13, 5.14, 5.15, and 5.16 Multiple CT-scan showing multicystic dysplastic kidneys. Note the different sizes of the cysts which are noncommunicating
•Multicystic dysplastic kidney complicated by hypertension is an indication for nephrectomy.
•The presence of a renal malignancy based on diagnostic imaging is an indication for nephrectomy.
–Some concern surrounds the possibility that the intervening stroma of a kidney
affected by multicystic dysplastic kidney might provide a focus for malignant degeneration.
–No increased risk of Wilms tumor has been demonstrated in patients with multicystic dysplastic kidney.
–Some authors recommend nephrectomy only in patients who do not show involution